Find your path to Andreas
172 people in our graph share verified history with Andreas — schools, employers, funds. One of them is your warm intro.
About
Andreas Niethammer is Chief Executive Officer of VAXIMM AG, which he founded in 2007 and where he also serves as Chief Medical Officer, developing oral cancer vaccines targeting VEGFR2 and personalized approaches. He previously served as Chief Medical Officer at Aardvark Therapeutics in San Diego from its inception, where he oversaw translational medicine and participated in Series A–C financing and the company's public offering. His clinical development experience spans oncology, immunology, and metabolic disorders, including immunotherapy, cancer vaccines, CAR T-cell and CAR-NK cell therapies, antibody drug conjugates, and gene therapy, with oversight of Phase 1 through Phase 4 trials.
Founder & Chief Executive Officer at Vaximm
Intro paths
In turn, Andreas can intro founders to Vaximm's investors below.
Vaximm's investors · 1
Experience
- VAXIMM AGChief Executive Officercurrent2025 — present
- VAXIMM AGChief Medical Officer2007 — 2025USA/Switzerland
- Heidelberg UniversityAssociate Professorcurrent2005 — presentHeidelberg, Germany
- Aardvark TherapeuticsChief Medical Officer2017 — 2025La Jolla, CA
- Fate Therapeutics IncVice President Clinical Development & Translational Medicine2017 — 2018La Jolla
- NantKwestChief Medical Officer2015 — 2017La Jolla
- PfizerSenior Director2012 — 2015La Jolla, CA
- PfizerDirector, Clinical Lead2011 — 2012
- Lilly-ImcloneMedical Director2010Heidelberg, Germany
- Pfizer, La JollaAssociate Director2007 — 2010
- Heidelberg, Department of Radiation OncologyProfessor, Board Certified Rad Onc Attending2003 — 2007
- The Scripps Research InstitutePost Doctoral Fellow2000 — 2003
- Charite BerlinResident1998 — 2000Virchow Klinikum
Skills & more
+8 more
PharmacologyMedical WritingPharmacovigilanceMedical AffairsRegulatory AffairsArzneimittelentwicklungKlinische ForschungKlinische EntwicklungLanguages English, German, French, Latin
From Andreas's professional profile.
Frequently asked questions
- Who is Andreas Niethammer?
- Andreas Niethammer is Chief Executive Officer of VAXIMM AG, which he founded in 2007 and where he also serves as Chief Medical Officer, developing oral cancer vaccines targeting VEGFR2 and personalized approaches. He previously served as Chief Medical Officer at Aardvark Therapeutics in San Diego from its inception, where he oversaw translational medicine and participated in Series A–C financing and the company's public offering. His clinical development experience spans oncology, immunology, and metabolic disorders, including immunotherapy, cancer vaccines, CAR T-cell and CAR-NK cell therapies, antibody drug conjugates, and gene therapy, with oversight of Phase 1 through Phase 4 trials.
- Where does Andreas Niethammer work?
- Andreas Niethammer is Founder & Chief Executive Officer of Vaximm.
- What companies did Andreas Niethammer found?
- Andreas Niethammer founded Vaximm.
- Where did Andreas Niethammer go to school?
- Andreas Niethammer studied at Heidelberg University (Habilitation, Experimental Oncology); Heidelberg, Dep. of Radiation Oncology (Board Certification Radiation Oncology, Habilitation in Experimental Oncology); Scripps Research (Postdoctoral Fellow, Tumor Immunology).
Founder mafias
Heidelberg University mafia35
Also came through, then founded or led a company.
+ 28 more
Scripps Research mafia15
Also came through, then founded or led a company.
+ 8 more
Kiel University mafia10
Also came through, then founded or led a company.
+ 3 more
Aardvark Therapeutics mafia2
Also came through, then founded or led a company.
Fate Therapeutics mafia2
Also came through, then founded or led a company.
Same school
Also attended Heidelberg University85
+ 79 more
Also attended Scripps Research20
+ 14 more
Also attended Kiel University16
.png)
+ 10 more
